articleAnnals of Internal MedicineJan 1, 2024Closed access

Osteoporosis

University of Minnesota · University of California, Los Angeles

PubMed
Indexed incrossrefpubmed

Abstract

Osteoporosis is a common systemic skeletal disorder resulting in bone fragility and increased fracture risk. Evidence-based screening strategies improve identification of patients who are most likely to benefit from drug treatment to prevent fracture. In addition, careful consideration of when pharmacotherapy should be started, choice of medication, and duration of treatment maximizes the benefits of fracture prevention while minimizing potential harms of long-term drug exposure.

Citation impact

162
total citations
FWCI
70.09
Percentile
100%
References
56
Citations per year

Authors

2

Topics & keywords

Keywords
  • Medicine
  • Osteoporosis
  • Pharmacotherapy
  • Fragility fracture
  • Intensive care medicine
  • Internal medicine
  • Bone mineral
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.